First case of pulmonary tuberculosis and visceral leishmaniasis coinfection successfully treated with antituberculosis drug and liposomal amphotericin B
نویسندگان
چکیده
KEY CLINICAL MESSAGE Successful management of cases with visceral leishmaniasis (VL) and tuberculosis is a challenge for clinicians, because a guideline for that is currently unavailable. We report the first case in Bangladesh who developed VL during her treatment for pulmonary tuberculosis and was treated successfully with multidose liposomal amhptericin B for VL.
منابع مشابه
Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challenge.
Visceral Leishmaniasis (VL) is an opportunistic infection amongst HIV-infected people in several endemic countries, and the clinical management of this co-infection poses several challenges. Here we describe a co-infected patient in India who failed to respond to miltefosine monotherapy and subsequently relapsed following two further (different) regimens of liposomal amphotericin B. He was then...
متن کاملMembranoproliferative Glomerulonephritis due to Visceral Leishmaniasis in an HIV Patient
BACKGROUND Visceral leishmaniasis is an important opportunistic disease in HIV-positive patients. The information available on the effects of such co-infection in the kidney is limited. We describe a patient with HIV/leishmania coinfection who developed nephrotic syndrome and membranoproliferative glomerulonephritis. As far as we know, only 2 cases of this nephropathy in HIV/leishmania coinfect...
متن کاملRecurrent visceral leishmaniasis in an immunocompetent patient: a case report
INTRODUCTION Current treatment options for visceral leishmaniasis (pentavalent antimony, amphotericin B, liposomal amphotericin B and mitelfosine) achieve long-term clinical cure in the majority of immunocompetent patients. Disease relapse is usually provoked by T-cell number or function impairment (corticosteroid or cytotoxic therapy, transplant recipients, advanced human immunodeficiency viru...
متن کاملLiposomal amphotericin B in the treatment of visceral leishmaniasis.
A case of visceral leishmaniasis unresponsive to several course of treatment with standard drugs, was successfully cured by a 21 day course (50 mg/day) of liposomal amphotericin B (AmBisome, Vestar Inc.). The efficacy of the AmBisome formulation is supported by experimental studies on Leishmania donovani infected BALB/c mice where ED50 values of AmBisome and conventional amphotericin B were 0.1...
متن کاملCase Report Immune Mediated Hemolysis in Visceral Leishmaniasis
Visceral leishmaniasis (VL) is an intracellular parasitic infection that infects and multiplies in the macrophages of the liver, spleen and bone marrow. It is characterized by intermittent fever, hepatosplenomegaly, pancytopenia and hypergammaglobulinemia. Anemia of multifactorial etiology is a usual manifestation of VL; however, Coombs positive hemolytic anemia has been infrequently reported i...
متن کامل